Cahill – Biomet Completes $1 Billion Notes Offering and Amended Credit Facility

Cahill represented the joint book-running managers and co-managers in the Rule 144A/Reg S offering of $1,000,000,000 6.5% Senior Notes due 2020 by Biomet, Inc., a leading orthopedic medical device company. Proceeds from the offering will be used to refinance existing indebtedness. Cahill also represented the dealer managers in connection with Biomet, Inc.’s tender offer for its outstanding 10 3/8% / 11 1/8% Senior Toggle Notes due 2017.

More >>

Tags:  Cahill Gordon & Reindel LLP | New York

Davis Polk – Korea Finance Corporation Notes Offering

Davis Polk advised Deutsche Bank AG, Singapore Branch, The Hongkong and Shanghai Banking Corporation Limited, The Korea Development Bank, Merrill Lynch, Pierce, Fenner & Smith Incorporated and Morgan Stanley & Co. International plc as underwriters in connection with a Schedule B debt offering by Korea Finance Corporation of $500 million in aggregate principal amount of its 2.25% notes due 2017.

More >>

Tags:  Davis Polk & Wardwell LLP | Hong Kong

Davis Polk – Vantiv, Inc. Secondary Offering

Davis Polk advised J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and Credit Suisse Securities (USA) LLC, as representatives of the underwriters, in connection with the $308 million SEC-registered secondary offering of 14,064,500 shares of Vantiv, Inc.’s Class A common stock by funds affiliated with Advent International Corporation and trusts affiliated with one of Vantiv’s directors, Pamela H. Patsley, at a price to the public of $21.90 per share. The underwriters’ over-allotment option to purchase additional shares of Class A common stock from the selling stockholders was exercised in full. The Class A common stock is listed on the New York Stock Exchange under the symbol “VNTV.”

More >>

Tags:  Davis Polk & Wardwell LLP | New York